Services
Find the Right Assays for Your Research
Immunoassay
Axela Bioscience provides cost-effective immunoassays using high multiplex or ultra-sensitive platforms to analyze minuscule samples. These assays quantify multiple biomarkers in various sample types. Services include pre-defined, mix-and-match, and custom panels for cytokines, transcription factors, and more, supporting research in cancer, inflammation, autoimmunity, and other diseases.
Immunology & Flow Cytometry
Axela Bioscience provides highly sensitive immune cell functional assays for drug discovery and development. These assays support research in immuno-oncology, autoimmune diseases, and infections by analyzing immune-tumor interactions. Covering drug screening to clinical trials, our services offer reproducible, high-throughput solutions for biomarker validation and efficacy studies in immunotherapy development.
CLIA-Certified Tests
Axela Biosciences, a CLIA-certified lab, offers specialized diagnostic services for biomarker-driven clinical development. Services include biomarker discovery, multi-platform analysis, LDT development, companion diagnostics, and sponsored testing programs. By integrating advanced technologies and adhering to high regulatory standards, Axela supports precision medicine, enabling targeted therapies and improved patient outcomes.
Spatial Biology
Spatial transcriptomics and proteomics map gene expression and protein distribution within tissues while preserving spatial context. These techniques reveal cellular interactions, tissue organization, and disease mechanisms, advancing research in cancer, neuroscience, and immunology. They aid in discovering biomarkers, therapeutic targets, and diagnostic tools, enhancing understanding of complex diseases.
Gene Array
qPCR Arrays enable gene expression profiling in various tissues and cells using pre-made or customized primers. Designed for high sensitivity and reproducibility, they detect minimal RNA quantities and support differential expression analysis. Available in multiple formats, these arrays facilitate cancer, pathway-related, and customized studies across diverse sample types, including FFPE tissues.
DMPK
Axela Bioscience offers comprehensive in vitro DMPK capabilities for drug development. Services include metabolic stability studies, CYP450 inhibition assays, plasma protein binding, blood-to-plasma partitioning, metabolite identification, permeability and transporter studies, drug stability assessments, and customized study designs. These regulatory-compliant assays support pharmacokinetics, drug-drug interaction analysis, and early-stage drug discovery.
